Updates
Skin Analytics achieves Class IIa UKCA Mark for DERM. The UK’s first and only Class IIa certified AI dermatology device
Now a Class IIa medical device, DERM, uses machine learning algorithms to recognise the most common malignant, pre-malignant and benign skin lesions, including melanoma – the fifth most common cancer in the UK. Using a decade’s worth of research and development on skin lesions, it is designed to accelerate patient diagnosis and relieve pressure on the healthcare system.
The Story So Far…
10 years. It barely seems credible to me that Skin Analytics is now a decade old. The last two years, in particular, have been such a blur that perhaps it’s a good time to take stock and think back on what we’ve learnt since beginning the company. No 6 St Chad’s...
Discussing the systematic review of skin cancer datasets in The Lancet: Skin Analytics response.
We were delighted to see research into the publicly available skin cancer datasets many use to train AI systems to assess skin cancer published in The Lancet Digital Health last week. Applying academic rigour to a long known issue around machine learning helps to...
Skin Analytics Receives NHSX Award for AI-Based Skin Cancer Tool
Deployment of unique diagnosis aid to be boosted across the NHS Currently deployed in University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, AI platform DERM will now be available to clinicians serving millions of patients around the...
Google’s move into skin cancer analysis is great news for patients and Skin Analytics
Google’s announcement of the culmination of three years of work and a subsequent move into skin disease analysis at their developer conference earlier this week has led to a number of people approaching me to ask what does this mean for Skin Analytics? Spoiler alert:...
Deploying Safe and Effective AI in Skin Cancer Pathways
26 January 2021 In December, the British Association of Dermatologist (BAD) President’s Bulletin included an article from Dr Rubeta Matin with an update from the recently formed BAD Artificial Intelligence Working Party Group. We wanted to welcome the formation of...
Skin Analytics response to NHS AI Code of Conduct
In July 2019 the Department of Health and Social Care and NHS England published a new code of conduct for the use of digital technology in health and care. As a company at the forefront of using AI algorithms to identify Skin Cancer, we know that AI provides...
Skin Analytics Awarded ISO 13485 Certification
Skin Analytics is delighted to announce that we are now ISO 13485:2016 certified. ISO 13485:2016 is an internationally recognised quality standard for medical devices and is a pre-requisite for registration as a class II medical device under the MDR. This...
Response: BMJ article: B2C apps not up to standard.
In February 2020, skin cancer researchers released a paper calling into question…
New data shows DERM, our AI skin cancer diagnosis tool, could be as accurate as clinical specialist
The prospective, diagnostic trial saw DERM, our AI platform, correctly identify all malignant lesions (100% sensitivity) with an average AUROC of 95.8% with 65% specificity versus 70% specificity and a 77% AUROC score demonstrated by the clinical experts. DERM, a CE marked medical device, was developed as a tool to aid clinicians in identifying 11 common skin lesion types, including melanoma.
Skin Analytics Have a New Office
As the team continues to expand, we've outgrown our existing office space and have moved to a new office in The Frames, 1 Phipp Street, EC2A 4PS. We've not moved far though, we remain in the heart of London's tech scene in Shoreditch. The new space will have some room...
Financial Support for Med-Tech Start-Ups
At Skin Analytics we have quite a few Google Alerts set so that we can keep up with the ever changing med-tech landscape. We were quite surprised to see our name pop up related to funding... Digital Health.london and RYSE asset management are calling for early stage...
CogX 2019 Winners
We are delighted to announce that the Skin Analytics have been recognised for their innovative work in AI, by CogX, the world’s leading festival of all things AI and emerging technology. The team were awarded Best Innovation in Computer Vision at the 2019 CogX Awards,...
AI for Skin Cancer… But we are NOT a technology business
It is true, we are not a technology company... Perhaps I should explain? When we started our journey to bring better access to high quality skin assessments we focused on how best to use technology do that. As with all blue sky ideas we have had to try quite a few...
Skin Analytics on CNN
Working in a startup that uses AI or Computer Vision to try and help improve health outcomes means that we are very familiar with the term CNN. In our world CNN means convolutional neural network which is a deep neural network used to classify images. (To all of the...